Various cellular targets involved in inflammation and oxidative stress

The term 'Various cellular targets involved in inflammation and oxidative stress' refers to a broad and heterogeneous group of biological molecules rather than a single, well-defined therapeutic target. This category encompasses a wide range of proteins, including transcription factors like NF-kappaB and Nrf2, enzymes such as COX-2 and iNOS, and signaling receptors like TLR4 (Source: PubMed, PMID: 29045954). Inflammation and oxidative stress are closely linked processes where the production of reactive oxygen species (ROS) can trigger inflammatory signaling, and vice versa, contributing to the pathogenesis of chronic diseases such as atherosclerosis and neurodegeneration (Source: NIH, StatPearls). Because this description covers a vast array of distinct molecular entities with diverse functions, it is considered an 'incorrect' target designation for structured drug discovery data. Effective pharmacological intervention requires the identification of specific, druggable nodes within these complex pathways to ensure therapeutic precision and safety (Source: Nature Reviews Drug Discovery). For instance, drugs like celecoxib target the COX-2 enzyme specifically, while dimethyl fumarate activates the Nrf2 pathway to combat oxidative damage (Source: PubChem). Broadly addressing 'inflammation and oxidative stress' as a single target is clinically impractical due to the risk of disrupting essential homeostatic functions.

Other names

Inflammatory and oxidative stress pathwaysRedox-sensitive inflammatory targetsMediators of chronic inflammation and oxidative damage

Varies significantly across the category; includes inhibition of pro-inflammatory enzymes (e.g., COX-2), activation of antioxidant response elements (e.g., Nrf2 pathway), and antagonism of pro-inflammatory cytokine receptors.